Pawlotsky, Jean-Michel

Publishing since 1992 (Senior)

Has published 187 publications in 19 years

Number of publications published per year by Pawlotsky, Jean-Michel. (Source : PubMed)

Distribution of publications types for Pawlotsky, Jean-Michel. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Pawlotsky JM, Chevaliez S. Preventing hepatitis C virus recurrence in liver transplant recipients: a role for adoptive immunotherapy?  Hepatology  2010;51;3  
•  Ahmed-Belkacem A, Ahnou N, Barbotte L, Wychowski C, Pallier C, Brillet R, Pohl RT, Pawlotsky JM. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.  Gastroenterology  2010;138;3  
•  Monto A, Schooley RT, Lai JC, Sulkowski MS, Chung RT, Pawlotsky JM, McHutchison JG, Jacobson IM. Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop.  Am. J. Gastroenterol.  2010  
•  Pawlotsky JM, Cocquerel L, Durantel D, Lavillette D, Lerat H, Pécheur EI, Polyak SJ, Tautz N, Thimme R. HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses.  Gastroenterology  2010;138;1  
•  Askarieh G, Alsiö A, Pugnale P, Negro F, Ferrari C, Neumann AU, Pawlotsky JM, Schalm SW, Zeuzem S, Norkrans G, Westin J, Söderholm J, Hellstrand K, Lagging M. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C.  Hepatology  2009  
•  Antaki N, Craxi A, Kamal S, Moucari R, Van der Merwe S, Haffar S, Gadano A, Zein N, Lai CL, Pawlotsky JM, Heathcote EJ, Dusheiko G, Marcellin P. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.  Liver Int.  2009  
•  Moreno C, Deltenre P, Pawlotsky JM, Henrion J, Adler M, Mathurin P. Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis.  J. Hepatol.  2009  
•  Lukasiewicz E, Gorfine M, Freedman LS, Pawlotsky JM, Schalm SW, Ferrari C, Zeuzem S, Neumann AU. Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment.  J. Viral Hepat.  2009  
•  Pawlotsky JM. [The liver and Europe]  Gastroenterol. Clin. Biol.  2009;33;8-9  
•  Pawlotsky JM. Hepatitis: HCV variability, the immune system and resistance to antiviral drugs.  Nat Rev Gastroenterol Hepatol  2009;6;7  

[ See timeline ] [ See all publications ]